Complejo Asistencial Universitario de León

León 24071

1 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer, Stroke, Ischemic, Systemic Embolism

Studies at this site

• The Fourth Left Atrial Appendage Occlusion Study — Recruiting now
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling